Facebook Instagram Linkedin Youtube
Home Tags GT-002

Tag: GT-002

Gabather's CEO Michael-Robin Witt in BioStock's studio.

BioStock Investor Pitch: Gabather

Gabather - alzheimer's disease

Gabather aims to impact the neurodegeneration field

Gabather - alzheimer's disease

Gabather’s aims to impact the neurodegeneration field

Gabather clinic

Gabather’s lead candidate moves forward in the clinic

Gabather poised to complete phase I with GT-002

BioStock Studio: Gabather gives clinical trial update

Q4 report points to progress in the clinic for Gabather

© BioStock 2024